There is a consensus that working on the ELTR data needs :
  • Approval by the ELTA Chairman and ELTR Committee
  • Financial contribution in case applicant is :

      - Pharmaceutical compagnies
      - Center non participating to ELTR

Formal guidelines contains :

  • Presentation of ELTR data as a whole
  • Mentionning the ELTR origin
  • If published, approved by the ELTA Chairman and the ELTR Custodian

Commercial use of the database :

  • Apart from sponsoring compagnies ( Novartis,Fujisawa and Roche Pharma), compagnies are subject to individual approval by ELTA committee.

Limitations on use of data :

  • Requested data will be utilized only in aggregate analysis. No center-specific analysis will be performed for any european center unless requested by the center

Back to the top

 

 
 
News - About ELTR - About ELTA - Participating centers - Results - Services - Publications -Links
Contact - Home - Credit